Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  245 results for ""Glucosides""

Your Filters

Geographic : japan
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jun 28; Vol. 23 (1), pp. 224. Date of Electronic Publication: 2024 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.

  • Authors : Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine, Tokyo, 113-8655, Japan. .; Herrington WG

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jun; Vol. 28 (6), pp. 588-595. Date of Electronic Publication: 2024 Apr 20.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan.

  • Authors : Tangri N; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada. .; Seven Oaks General Hospital, 2LB19-2300, McPhillips Street, Winnipeg, MB, R2V 3M3, Canada. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Advances in therapy [Adv Ther] 2024 Mar; Vol. 41 (3), pp. 1151-1167. Date of Electronic Publication: 2024 Jan 19.Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Empagliflozin cost-effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction.

  • Authors : Tsutsui H; School of Medicine and Graduate School, International University of Health and Welfare, Tokyo, Japan.; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Benzhydryl Compounds*

  • Source: ESC heart failure [ESC Heart Fail] 2024 Feb; Vol. 11 (1), pp. 261-270. Date of Electronic Publication: 2023 Nov 15.Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan.

  • Authors : Kodera S; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.; Morita H

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy; Humans

  • Source: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2022 Nov 25; Vol. 86 (12), pp. 2021-2028. Date of Electronic Publication: 2022 Sep 06.Publisher: Japanese Circulation Society Country of Publication: Japan NLM ID: 101137683 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall-a sub-analysis of the UTOPIA trial.

Subjects: Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Carotid Arteries/Carotid Arteries/Carotid Arteries/*drug effects ; Carotid Artery Diseases/Carotid Artery Diseases/Carotid Artery Diseases/*drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Feb 05; Vol. 21 (1), pp. 19. Date of Electronic Publication: 2022 Feb 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.

  • Authors : Okura T; Division of Cardiovascular Medicine, Endocrinology and Metabolism, Tottori University Faculty of Medicine, 36-1 Nishi-Cho, Yonago, Tottori, 683-8504, Japan. .; Fujioka Y

Subjects: Insulin Resistance*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Scientific reports [Sci Rep] 2022 Feb 03; Vol. 12 (1), pp. 1896. Date of Electronic Publication: 2022 Feb 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).

  • Authors : Tobe K; First Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, 930-0194, Japan.; Maegawa H

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucosides/Glucosides/Glucosides/*administration & dosage ; Liver/Liver/Liver/*drug effects

  • Source: Endocrine journal [Endocr J] 2021 Aug 28; Vol. 68 (8), pp. 905-918. Date of Electronic Publication: 2021 Apr 08.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin.

Subjects: Glycemic Control*; Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Jul 31; Vol. 20 (1), pp. 160. Date of Electronic Publication: 2021 Jul 31.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial.

Subjects: Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Jun 28; Vol. 20 (1), pp. 105. Date of Electronic Publication: 2021 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  245 results for ""Glucosides""